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ABSTRACT:
This is a case of cerebral venous sinus thrombosis (CVST) as a rare complication of varicella Zoster infection. A young
male with no significant medical history presented with generalized tonic clonic seizures preceded by vesicular rash on
the face diagnosed as Varicella zoster infection. The MRI showed bilaterial superficial hemorrhagic infarcts involving
frontal and temporal lobes and MR Venogram was consistent with extensive CVST involving superioir sagittal, right
transverse and superficial veins. After initial treatment with antiepileptic and anticoagulant, he showed marked
improvement in symptomatology and made complete recovery subsequently with recanalization of sinuses seen on a
follow up MRV done at fourth month. Our case emphasizes on having a high suspicion of Varicella Zoster infection in
patient who presents with CVST with an underlying ongoing Rash or a prior history of recent body Rash.

CASE PRESENTATION
and bacterial cultures of CSF were negative. CSF
showed presence of IgG varicella antibodies. Protein C
and S levels were normal but serum homocysytiene
level was elevated (32 mc moles/L). He was given
intravenous Acyclovir with adequate hydration and was
continued on oral Levetiracetam. He was started on low
molecular weight heparin (1 mg/kg SQ every 12 hours).
His general condition improved gradually. He became
afebrile and the cutaneous lesions continued to crust.
His headache disappeared and no seizure recurrence
was observed. He became alert and oriented while
hemiparesis improved. A follow up MRI showed
recanalization of venous sinuses after 4 months with no
lesions in brain parenchyma. He was continued on
anticoagulation for 3 months with an unremarkable
course of recovery.

A 36 years old previously healthy male with no
co-morbids and no significant past medical history,
presented to a local hospital ER with new onset seizure.
He had a history of vesicular rash involving multiple
dermatomes 2 weeks ago. During the illness he
developed high grade intermittent fever up to 102 ˚F
along with severe diffuse headache. He was treated
conservatively with antipyretics and was discharged
home. In the second week of his illness, he suffered
three brief episodes of generalized tonic clonic
seizures. He was taken to ER where he was given
intravenous Diazepam and loaded with Leviteracetam.
On general physical exam the patient had cutaneous
lesions that was partly crusting, was diagnosed as
“shingles” by our infectious disease expert. On
neurological examination he was drowsy and
disoriented with right hemiparesis. Brain MRI showed
bilaterial superficial hemorrhagic infarcts involving
frontal and temporal lobes and MRVenogram showed
extensive CVST involving superioir sagittal sinus, right
transverse sinus and superficial veins. The laboratory
investigations revealed a high Total Leukocyte Count
(20.8 x109). Liver function tests, hepatitis B and C
serology, cerebrospinal fluid (CSF) analysis were all
within normal limits. Polymerase chain reaction tests
for Herpes simplex virus (HSV) Mycobacterium
tuberculosis and, India ink stain, cryptococcal antigen
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DIAGNOSTIC AND TREATMENT ALGORITHM
Stroke and CVT is a well-known complication of VZV. It
must be suspected in all patients with typical skin
lesions and neurological findings especially focal
neurological deficits. Brain imaging is a must preferably
contrast MRI and MR venogram. Meningoencephalitis
is not uncommon in patients with neurological
involvement. A lumbar puncture should be done unless
contra indicated in all patients. Cerebral VZV infection
can be identified by IgG antibodies against VZV. Many
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diagnostic kits (for example Biofilm array) include VZV
in their panel for meningoencephalitis. If not included in
panel, it could be ordered separately. These antibodies
are considered diagnostic for cerebral VZV infection.
VZV infections are effectively treatable with acyclovir
IV(10 mg per kg three times a day) for 10-14 days. CVT
is treated with anticoagulation (Low Molecular weight
heparin) for 3-7 days followed by oral anticoagulation.
Newer anticoagulants are currently preferred choice for
long term anticoagulation as compared to warfarin. In
the absence of any hypercoaguable state most patients
require 3-6 months anticoagulation. Seizure are
treated with anti-epileptic drugs for six months or more.
Most patients with acute CVT and seizures do not
require long terms (2-23 years) AEDs.

vessels providing an anatomic pathway for virus to
spread, direct endothelial damage by the virus hence
provoking thrombosis. There also has been a temporal
link postulated between development of skin lesions
and thrombotic complications. The latency period of
2-3 weeks is the time during which endothelial damage
occurs leading to a widespread thrombotic process (4).
Patients with a pro-coagulant state like protein C and S
deficiency and raised homocysteine level have also
shown high occurrence of thrombosis (3). In VZV
vasculopathy patients may not always have VZV DNA in
cerebrospinal fluid (CSF) but diagnosis can be
confirmed with anti-VZV antibodies in CSF (2). Our
patient not only had high homocysteine levels making
him more susceptible to CVST, but also showed
presence of IgG varicella antibodies in CSF. This report
provides an insight into rare manifestations of varicella
infection in adults. Studies investigating the possible
mechanism of development of CVST would allow for
improved management and therefore better outcomes
in these patients.

DISCUSSION
Varicella Zoster virus (VZV) is known to cause a benign
self-limiting exanthem in children rarely with any
neurological manifestations. However, with increasing
incidence of VZV in adult population, severe
neurological manifestations have been reported with
cerebellar ataxia and encephalitis being the most
common. VZV is also associated with cerebral
vasculopathy including cerebral artery stenosis,
vasculitis,
large
artery
disease,
aneurysm,
subarachnoid hemorrhage and cerebral venous sinus
thrombosis (CVST) (1). Venous thrombosis secondary to
VZV is rare and may occur both during primary infection
as well as reactivation of virus. Patel et al. report the
case of a 25-year old male with recent history of VZV
infection presenting with severe throbbing headache
and status epilepticus. CT revealed significant
thrombosis in left transverse, straight and sigmoid
sinuses confirming the diagnosis of CVST (2). Headache
and seizure history were also present in our case.
Siddiqi et al. described two cases of CVST associated
with VZV in protein C and S deficient patients (3). Other
cases of CVST associated with VZV have also been
reported in literature and one patient was reported to
have both CVST and pulmonary embolism secondary to
VZV due to widespread thrombosis (4-6). VZV associated
cerebral venous sinus thrombosis is attributed to blood
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Figure 1; FLAIR image of brain showing
right temporal hemorrhagic infarct

32

VOL. 15 (3)

J U LY- S E P 2 0 2 0

References:
1. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA.
Varicella zoster virus vasculopathies: diverse
clinical manifestations, laboratory features,
pathogenesis, and treatment. The Lancet
Neurology. 2009;8(8):731-40.

4. Khan R, Yasmeen A, Pandey AK, Al Saffar K,
Narayanan SR. Cerebral venous thrombosis and
acute pulmonary embolism following varicella
infection. European journal of case reports in
internal medicine. 2019;6(10).

2. Patel U, Ranjan R, Agrawal C, Patel N. Primary
Varicella Zoster Infection Presented with Cerebral
Venous Sinus Thrombosis in Adult. International
Journal of Health Sciences and Research (IJHSR).
2015;5:568-72.

5. Gayathri K, Ramalingam P, Santhakumar R,
Manjunath B, Karuppuswamy N, Vetriveran B, et
al. Cerebral sinus venous thrombosis as a rare
complication of primary varicella zoster virus
infection.
J
Assoc
Physicians
India.
2016;64(7):74-6.

3. Siddiqi SA, Nishat S, Kanwar D, Ali F, Azeemuddin
M, Wasay M. Cerebral venous sinus thrombosis:
association with primary varicella zoster virus
infection. Journal of Stroke and Cerebrovascular
Diseases. 2012;21(8):917. e1-. e4.

6. Sudhaker B, Dnyaneshwar MP, Jaidip CR, Rao SM.
Cerebral venous sinus thrombosis (CVST)
secondary to varicella induced hypercoagulable
state in a adult. Intern Med Inside. 2014;2:1.

Conflict of interest: There is no conflict of interest..
Funding disclosure: Nil
Author’s contribution:
Asma Akbar Ladak; data collection, data analysis, manuscript writing, manuscript review
Salman farooq; data analysis, manuscript writing, manuscript review

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

33

VOL. 15 (3)

J U LY- S E P 2 0 2 0

